Shannon M. Mumenthaler

Expression of arginase II in prostate cancer.

Disruption of arginase II alters prostate tumor formation in TRAMP mice.

CD4+ NK cells can be productively infected with HIV, leading to downregulation of CD4 expression and changes in function.

Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes.

Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer.

Cancer as a moving target: understanding the composition and rebound growth kinetics of recurrent tumors.

A physical sciences network characterization of non-tumorigenic and metastatic cells.

The Need for Integrative Computational Oncology: An Illustrated Example through MMP-Mediated Tissue Degradation.

Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments.

Predictive Modeling of Drug Response in Non-Hodgkin's Lymphoma.

The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells.

Phosphorylated ribosomal S6 (p-rpS6) as a post-treatment indicator of HER2 signalling targeted drug resistance.

Significance of duon mutations in cancer genomes.

A high-content image-based method for quantitatively studying context-dependent cell population dynamics.

Dual transcript and protein quantification in a massive single cell array.

Leveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid Tumors.

Quantifying differences in cell line population dynamics using CellPD.

Single cell dynamic phenotyping.

Progress Towards Computational 3-D Multicellular Systems Biology.